Skip to main content
ViatrisEarnings

Viatris Reports Third-Quarter 2026 Financial Results

Source: Autobound Signal API · 76 signals tracked for Viatris · updated

Get Viatris' live signals in Claude or ChatGPT, or by API

AskWhat changed at Viatris this week? Use Autobound signals for viatris.com.

What happened

Viatris reported a U.S. GAAP net loss of $(325.3) million for the third quarter of 2026.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

PITTSBURGH , Nov. 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ), a global healthcare company, today announced its third-quarter 2026 financial results. Executive Commentary "Our third-quarter results reflect strong execution and reinforce our confidence in the growth trajectory of our business," said Scott A. Smith, CEO, Viatris. "Momentum across key areas of our base business, progress in our pipeline and the benefits of our enterprise-wide strategic review continue to strengthen our company. With the recent U.S. launch of Gwyn Lo, approvals of RYZUMVI in the U.S. and WAKIX in Japan, the potential upcoming approval and launch of fast-acting meloxicam and our recently announced agreement to acquire Pacira BioSciences, we are taking important steps to position Viatris for sustained revenue and earnings growth." "We are very pleased with the operational momentum across our higher-margin businesses and continued focus on cost discipline, which led to strong overall third-quarter results," said Paul Campbell, Interim CFO, Chief Accounting Officer & Corporate Controller, Viatris. "Based on this performance and our confidence in the outlook for the rest of the year, we are once again raising the midpoints of our financial guidance ranges across all key metrics. Also, consistent with our disciplined and balanced capital allocation strategy, we continued returning...

Keep reading with a free account

The rest of this article, and every signal for Viatris, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

Amount named
$325
Takes effect
Nov 5, 2026
Location
Pittsburgh, Pennsylvania, United States

The full record

From the Signal API record

Numbers

Amount named in the story
$325

Details

Ticker
NASDAQ:VTRS

Extraction

Confidence
95%
Detected
Nov 5, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Viatris and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Viatris this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/88d73984-c07b-d6c3-e1d8-68fd832f71ec returns this record as JSON. POST /v1/companies/enrich returns every signal for viatris.com.

{
  "signal_id": "88d73984-c07b-d6c3-e1d8-68fd832f71ec",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-11-05T11:59:00+00:00",
  "company": {
    "name": "Viatris",
    "domain": "viatris.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/viatris-reports-third-quarter-2026-financial-results-302929937.html",
    "title": "Viatris Reports Third-Quarter 2026 Financial Results",
    "ticker": "NASDAQ:VTRS",
    "excerpt": "PITTSBURGH , Nov. 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ), a global healthcare company, today announced its third-quarter 2026 financial results. Executive Commentary \"Our third-quarter results reflect strong execution and reinforce our confidence in the growth trajectory of our business,\" said Scott A. Smith , CEO, Viatris. \"Momentum across key areas of our base business, progress in our pipeline and the benefits of our enterprise-wide strategic review continue to strengthen our company. With the recent U.S. launch of Gwyn Lo, approvals of RYZUMVI in the U.S. and WAKIX in Japan, the potential upcoming approval and launch of fast-acting meloxicam and our recently announced agreement to acquire Pacira BioSciences, we are taking important steps to position Viatris for sustained revenue and earnings growth.\" \"We are very pleased with the operational momentum across our higher-margin businesses and continued focus on cost discipline, which led to strong overall third-quarter results,\" said Paul Campbell , Interim CFO, Chief Accounting Officer & Corporate Controller, Viatris. \"Based on this performance and our confidence in the outlook for the rest of the year, we are once again raising the midpoints of our financial guidance ranges across all key metrics. Also, consistent with our disciplined and balanced capital allocation strategy, we continued returning additional...",
    "summary": "Viatris reported a U.S. GAAP net loss of $(325.3) million for the third quarter of 2026.",
    "location": "Pittsburgh, Pennsylvania, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS2027816/3Q2026-Earnings-Release-FINAL-PDF.pdf?id=OA3059548&p=pdf&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-11-05T11:59:00Z",
    "location_data": [
      {
        "city": "Pittsburgh",
        "state": "Pennsylvania",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-05",
    "article_sentence": "PITTSBURGH , Nov. 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ), a global healthcare company, today announced its third-quarter 2026 financial results.",
    "amount_normalized": 325
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.